This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System Hemangioblastomas | MicrobiomeTrials
← Back to trials NCT07705529
Pediatric Von Hippel-Lindau Disease: Natural History, Predictive Factors, and Long-Term Functional Outcomes of Central Nervous System Hemangioblastomas Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-15Est. Completion: 2027-07-15
Enrollment target: 25 participantsLocations Hôpital Roger Salengro, CHU Lille, Lille, France Hôpital Femme Mère Enfant, HCL, Lyon, France Hôpital Necker, Paris, France Other microbiome trials you might be interested in Von Hippel-Lindau Disease Malignant Neoplasms
Researchers are looking for new ways to treat advanced solid tumors and von Hippel-Lindau (VHL)-related tumors:
* Advan…
Boston, United States Est. completion Jan 14, 2034
Adenocarcinoma Prostate Neoplasms Prostate Cancer Renal Cell Carcinoma Von Hippel Lindau Disease
This study will evaluate the accuracy and effectiveness of an experimental tracking device for locating abnormalities du…
Bethesda, United States Completed Aug 2, 2028
Kidney Cancer Urologic Malignant Disorders Renal Cell Carcinoma Familial Renal Cancer (FRC) Clear Cell Renal Cancer
We will investigate the clinical manifestations and molecular genetic defects of heritable urologic malignant disorders.…
Bethesda, United States